A single arm confirmatory study of nivolumab in patients with previously treated advanced sarcomatoid carcinoma of the lung
Latest Information Update: 24 Nov 2021
At a glance
- Drugs Nivolumab (Primary)
- Indications Carcinoma; Lung cancer
- Focus Therapeutic Use
- 06 Jun 2020 Status changed from recruiting to active, no longer recruiting.
- 04 Jun 2017 Status changed from not yet recruiting to recruiting.
- 04 Nov 2016 New trial record